PREDiCT: Tumour Models London 2020

Tuesday 1 December 2020 to Thursday 3 December 2020

Advancing In-vivo and emerging 3D/ex-vivo platforms, for comprehensive study of efficacy, safety, and immune response.

This year, the PREDiCT: 9th Tumour Models London will unite Preclinical and Translational Oncology Scientists to fast-track oncology therapeutics into clinic through enhanced model platforms and selection strategy. In recent times, we have seen the uptake of new preclinical models that boost our understanding of immuno-oncology therapies, as well as emerging 3D platforms for more comprehensive study of target validation and immune response. Reflecting these developments, our 2020 Case Studies Include:

- Roche discusses what we need for next gen model to enhance predictability and targeting?
- Genmab shares compares Humanized Models for the Study of T-Cell Engaging Bispecifics in Vivo
- GSK improves the safety predictability of IO modalities with Organ On Chip (OoC) models
- Dana Faber Cancer institute reveals RNA-sequencing analysis of immunotherapy response in organotypic tumor spheroids
- Institute of Cancer Research shares the Imaging of PD-L1 in head and neck cancer in response to oncolytic virotherapy

Event Information

Organiser
Hanson Wade
Location
Online
Online
00000
United Kingdom
This event is under the auspices of UICC
No
Last update: 
Monday 26 October 2020
Share